Macular degeneration overview
|
Macular degeneration Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Macular degeneration overview On the Web |
|
American Roentgen Ray Society Images of Macular degeneration overview |
|
Risk calculators and risk factors for Macular degeneration overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Macular degeneration is a medical condition predominantly found in elderly adults in which the center of the inner lining of the eye, known as the macula area of the retina, suffers thinning, atrophy, and in some cases bleeding. This can result in loss of central vision, which entails inability to see fine details, to read, or to recognize faces. According to the American Academy of Ophthalmology, it is the leading cause of central vision loss (blindness) in the United States today for those over the age of fifty years.[1] Although some macular dystrophies that affect younger individuals are sometimes referred to as macular degeneration, the term generally refers to age-related macular degeneration (AMD or ARMD).
Differentiating Macular Degeneration from other Diseases
Macular degeneration should be differentiated from other causes of distorted vision with a very different etiology and different treatment such as epiretinal membrane or macular pucker or leaking blood vessels in the eye.
Natural History, Complications and Prognosis
Macular degeneration, in its advanced forms, can result in legal blindness, resulting in a loss of driving privileges and an inability to read all but very large type. Perhaps the most grievous loss is the inability to see faces clearly or at all. Some of these losses can be offset by the use of adaptive devices. A closed-circuit television reader can make reading possible, and specialized screen-reading computer software, e.g., JAWS for Windows, can give the blind person access to word processing, spreadsheet, financial, and e-mail access.
Diagnosis
Other Diagnostic Studies
Fluorescein angiography allows for the identification and localization of abnormal vascular processes. Optical coherence tomography is now used by most ophthalmologists in the diagnosis and the followup evaluation of the response to treatment by using either Avastin or Lucentis which are injected into the vitreous of the eye at various intervals.
References
- ↑ de Jong PT (2006). "Age-related macular degeneration". N Engl J Med. 355 (14): 1474–1485. PMID 17021323.